Skip to main content
. 2016 Jul 5;7(9):835–840. doi: 10.1021/acsmedchemlett.5b00407

Scheme 1.

Scheme 1

Reagents and conditions: (a) NH2OH·HCl, 95% ethanol, MeOH, 60 °C, 2 h; (b) Pd/C, H2, THF, rt, 4 h; (c) 4-acetamido benzenesulfonyl chloride, toluene, pyridine, 100 °C, 2 h, 71%; (d) DMF, K2CO3, bromoacetonitrile, rt, 3 h, 53%; (e) DMF, K2CO3, 3-bromoprop-1-yne, rt, 3 h, 59%; (f) DMF, K2CO3, methyl bromoacetate, rt, 3 h, 54%; (g) DMF, K2CO3, 2-bromoacetamide, rt, 3 h, 64%; (h) DMF, NH4Cl, NaN3, N2, 100 °C, 6 h, 67%; (i) DMF, NH4Cl, NaN3, N2, 100 °C, 6 h, 63%; (j) NH2OH·HCl, NaOH (aq), MeOH, rt, 6 h, 64%; (k) LiAlH4, THF, NaOH (aq), rt, 3 h, 51%; (l) LiOH, CH3OH/H2O, rt, 6 h, 68%.